Viking Therapeutics Inc. (VKTX)
34.13
0.20 (0.59%)
At close: Jan 15, 2025, 12:39 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -85.89M | -68.87M | -54.99M | -39.49M | -25.78M | -22.06M | -20.58M | -14.73M | -23.40M | -21.88M | -146.25K | -444.11 |
| Depreciation & Amortization | 292.00K | 291.00K | 296.00K | 277.00K | 260.00K | 477.00K | 1.38M | 1.94M | 1.03M | n/a | n/a | n/a |
| Stock-Based Compensation | 16.75M | 8.67M | 6.10M | 5.82M | 3.74M | 2.61M | 1.45M | 1.79M | 2.60M | 6.26K | 3.55 | 22.45 |
| Other Working Capital | 4.25M | 3.10M | -383.00K | 6.16M | -5.25M | 1.33M | 1.51M | 172.69K | 401.08K | 21.75M | 5.38K | n/a |
| Other Non-Cash Items | -8.07M | 1.32M | 29.00K | 138.00K | 334.00K | -208.00K | 2.50M | 862.62K | 11.32M | -1.65M | 42.57K | 244.11 |
| Deferred Income Tax | n/a | n/a | 3.91M | 3.77M | 473.00K | -392.00K | -1.28M | -1.79M | -893.50K | n/a | n/a | n/a |
| Change in Working Capital | 3.55M | 10.19M | -2.93M | 7.72M | -3.78M | 823.00K | 1.77M | 849.88K | 620.32K | 21.94M | 25.44K | n/a |
| Operating Cash Flow | -73.38M | -48.40M | -47.59M | -21.78M | -24.75M | -18.75M | -14.76M | -11.07M | -8.73M | -1.59M | -78.23K | -200 |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -478.30M | -121.43M | -168.01M | -280.64M | -362.41M | -348.20M | -22.53M | -16.92M | -16.03M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 299.22M | 176.18M | 205.97M | 322.20M | 369.87M | 82.47M | 20.80M | 19.95M | 2.56M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 54.75K | 37.96K | 41.57K | 7.46K | -265.73K | -1.73K | 3.03K | -13.47K | n/a | n/a | n/a |
| Investing Cash Flow | -179.09M | 54.75M | 37.96M | 41.57M | 7.46M | -265.73M | -1.73M | 3.03M | -13.47M | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | -3.83M | -77.00K | -94.86K | n/a | 2.50M | 260.35K | n/a |
| Common Stock Repurchased | -7.12M | -6.79M | -707 | -296 | -151 | n/a | n/a | -229 | -38 | -2 | -2.50K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 271.38M | 10.96M | 6.88M | 950.00K | 887.00K | 7.50M | 125.45K | -1.10M | -3.18M | -332.34K | n/a | 200.00 |
| Financial Cash Flow | 271.38M | 4.16M | 6.88M | 950.00K | 887.00K | 300.27M | 22.40M | 10.35M | 22.21M | 2.17M | 257.85K | 200.00 |
| Net Cash Flow | 18.88M | 10.26M | -2.75M | 20.74M | -16.40M | 15.79M | 5.91M | 2.31M | 12.69K | 576.24K | 179.62K | n/a |
| Free Cash Flow | -73.38M | -48.40M | -47.59M | -21.78M | -24.75M | -18.75M | -14.76M | -11.07M | -8.73M | -1.59M | -78.23K | -200 |